🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Not that this ever happens 😏, but what if you can’t get good PCWPs during invasive exercise RHC? Lean instead on Ex PAC & RAPs to distinguish pre- & post-cap disease. Kudos to ⭐️ ⁦The Osler Medical Residency⁩ Dr. Maggie Montovano for this great work! pmc.ncbi.nlm.nih.gov/articles/PMC11…

Congrats to Yoo Jin Kim on one of her many oral abstract presentations at #AHA24 today!

Feeling inspired after a great weekend at #AHA2024 with the best co-residents! And a huge thank you to my incredible mentors, Luigi Adamo & Steven Hsu, for the opportunities to present at AHA this year! The Osler Medical Residency Abhi Gami #Strongcope #Longcope

Collaborative work with Luigi Adamo and team on a severe complication of myositis patients- myocarditis!

Just out: The anonymous infectious disease doctor is back with a post about how ID docs and Public Health experts are responding incorrectly to RFK Jr. The media could learn something drvinayprasad.com/p/suggestions-…

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above

I just listened to the full remarks of Vice President JD Vance at the Munich Security Conference. He made some excellent points about democracy and free speech. I think it’s worth listening firsthand youtube.com/live/pCOsgfINd… via YouTube

Thank you to Poltorak Lab Zoie Magri, PhD Pilar Alcaide, PhD for making this study possible. Previous papers on T-Myd88 at Circulation Research (ahajournals.org/doi/10.1161/CI…) and The American Journal of Pathology (sciencedirect.com/science/articl…)

Among patients with systemic lupus erythematosus (SLE), 20.3% experienced recurrent pericarditis, with younger age, active SLE, and oral prednisone treatment being risk factors for recurrence. ja.ma/4hQfxyj

Our Co-Director, Dr. Rick Carrick, and Director, Dr. Jose Madrazo, of our Hypertrophic Cardiomyopathy Program want to remind you it's #HCMAwarenessDay! Our program was recently recognized as a center of excellence by @4hcm 👏🫀

Thanks a lot! I am not sure about the star and the guru… but the rest is accurate :-)

Are we entering the age of the cardio-rheumatology clinic ❓ 🗨️“The field is absolutely necessary, but it is still evolving" We talked w/ Luigi Adamo, Julie J. Paik, heba wassif, Brittany Weber & more to explore the potential of this crossover 👇 healio.com/news/rheumatol…

Congratulations to Jana Lovell ⁦Johns Hopkins Cardiology⁩ ⁦Johns Hopkins Medicine⁩ star Adamo Lab member for winning 1st place at ⁦American College of Cardiology⁩ Young Investigator Award - Basic Science ⁦Kavita Sharma⁩ - The future is bright for cardiology!

Great piece on cardio-immunology / cardio-rheumatology on healio healio.com/news/rheumatol…

“To understand the rise of cardio-rheumatology, we need to look at the rise of cardio-immunology, which is the research field investigating the relationship between the immune system and the heart,” said Dr. Luigi Adamo. bit.ly/4j9UTt6

Congrats to super⭐️ ⁦Johns Hopkins Ciccarone Center⁩ physician-scientist-educator ⁦Anum Minhas⁩ on her award for top young author for ⁦JACC Journals⁩ JACC Advances & her recognition as a top mentor too! ⁦Johns Hopkins Cardiology⁩

The 2025 Douglas P. Zipes Distinguished Young Scientist Award goes to Brittany Weber, MD, PhD, FACC. Her trailblazing work in cardiac rheumatology is changing the landscape of coronary vascular health. #ACC25 Brittany Weber youtube.com/watch?v=9E1lJW…

🔁Pericarditis recurred in 20.3% of patients with #lupus vs. around 30% of the general population “This raises interesting questions about whether the underlying immunomodulatory treatment in lupus patients is the driving factor,” Luigi Adamo said healio.com/news/rheumatol…

The Evolving Role of Colchicine in Coronary Atherosclerosis Management: Timing May Be Everything ⁦ ACC Media Center⁩ ⁦Anandita Agarwala Kulkarni, MD FACC⁩ ⁦Eugenia Gianos MD⁩ ⁦Eugene Yang⁩ ⁦Johns Hopkins Ciccarone Center⁩ ⁦AntonioAbbate⁩ #cvPrev acc.org/Latest-in-Card…

Nice summary of recent colchicine trials led by ⭐️ University of Maryland School of Medicine student Anum Zehra & our #10⚽️ Abhi Gami: Defining the optimal timing of colchicine therapy initiation post MI may better inform its use for secondary ASCVD prevention. #Cardiology